At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
AMA RUC Upcoming Surveys
Over the next several weeks, a significant number of CPT® codes used to report audiology function tests will undergo review through the AMA/Specialty Society Relative…
Motion Intolerance Causes and Treatment Options
A recent online publication (Shevtsov, 2026) discussed ways to manage motion intolerance. Motion intolerance, also known as motion sickness, is theorized to occur when there…
Q4 SPAN Meeting to Focus on the ASLP-IC Compact
The American Academy of Audiology’s State Policy Advocate Network (SPAN) will hold its fourth-quarter meeting on October 28, 2026, from 8:00–9:00 pm ET. The meeting…



